Clinical trial
Metabolic Effects of Thiazolidinediones in Chronic Kidney Disease
NCT00368017 · Vanderbilt University, Other · Terminated
Key facts
| NCT number | NCT00368017 |
|---|---|
| Title | Metabolic Effects of Thiazolidinediones in Chronic Kidney Disease |
| Official title | Metabolic Effects of Thiazolidinediones in Chronic Kidney Disease |
| Lead sponsor | Vanderbilt University, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease |
| Intervention type | Drug |
| Interventions | pioglitazone, placebo |
| Enrollment | 12 |
| Start date | Apr 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Aug 24, 2006 |
| Last update posted | Nov 3, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: